Nature Reviews Cancer

(The TQCC of Nature Reviews Cancer is 120. The table below lists those papers that are above that threshold based on CrossRef citation counts. The publications cover those that have been published in the past four years, i.e., from 2019-03-01 to 2023-03-01.)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy1235
The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism685
The blood–brain barrier and blood–tumour barrier in brain tumours and metastases592
Tertiary lymphoid structures in the era of cancer immunotherapy581
Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion524
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data465
The lung microenvironment: an important regulator of tumour growth and metastasis454
Modelling cancer in microfluidic human organs-on-chips429
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy380
Phagocytosis checkpoints as new targets for cancer immunotherapy358
Unmasking senescence: context-dependent effects of SASP in cancer338
Targeting transcription factors in cancer — from undruggable to reality336
The broken cycle: E2F dysfunction in cancer326
Improving cancer immunotherapy through nanotechnology320
Diverging inflammasome signals in tumorigenesis and potential targeting317
Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells284
Epigenetic therapy in immune-oncology275
How the ageing microenvironment influences tumour progression274
Therapeutically exploiting STAT3 activity in cancer — using tissue repair as a road map262
Brain immunology and immunotherapy in brain tumours248
Controversies around epithelial–mesenchymal plasticity in cancer metastasis223
γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer187
YAP and TAZ: a signalling hub of the tumour microenvironment186
Phenotype plasticity as enabler of melanoma progression and therapy resistance185
Targeting cancer vulnerabilities with high-dose vitamin C185
Methionine metabolism in health and cancer: a nexus of diet and precision medicine178
Clinical actionability of molecular targets in endometrial cancer172
Fluids and their mechanics in tumour transit: shaping metastasis157
Extrachromosomal oncogene amplification in tumour pathogenesis and evolution156
Context-dependent roles of complement in cancer150
Cancer overdiagnosis: a biological challenge and clinical dilemma148
Alternative tumour-specific antigens146
Cytokinesis defects and cancer144
Altered cellular metabolism in gliomas — an emerging landscape of actionable co-dependency targets131
Brain metastasis127
Genomic evolution of cancer models: perils and opportunities123
Immune control by amino acid catabolism during tumorigenesis and therapy120